In a filing, Disc Medicine Inc revealed its Chief Medical Officer Savage William Jacob unloaded Company’s shares for reported $0.15 million on Jun 06 ’25. In the deal valued at $50.00 per share,2,996 shares were sold. As a result of this transaction, Savage William Jacob now holds 56,725 shares worth roughly $3.05 million.
Then, WILLIAM SAVAGE bought 2,996 shares, generating $143,838 in total proceeds.
Before that, Savage William Jacob sold 6,677 shares. Disc Medicine Inc shares valued at $334,128 were divested by the Chief Medical Officer at a price of $50.04 per share. As a result of the transaction, Savage William Jacob now holds 59,721 shares, worth roughly $3.21 million.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in late February with a ‘”a Buy”‘ rating. Morgan Stanley also remained covering IRON and has increased its forecast on November 05, 2024 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Raymond James revised its rating on November 04, 2024. It rated IRON as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of IRON
On Friday, Disc Medicine Inc [NASDAQ:IRON] saw its stock jump 1.90% to $53.71. Over the last five days, the stock has gained 7.38%. Disc Medicine Inc shares have fallen nearly -15.28% since the year began. Nevertheless, the stocks have risen 37.26% over the past one year. While a 52-week high of $68.73 was reached on 01/02/25, a 52-week low of $30.82 was recorded on 04/09/25.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 52.11, which if violated will result in even more drops to 50.51. On the upside, there is a resistance level at 54.72. A further resistance level may holdings at 55.73.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-05-30, dropping by -0.12 million shares to a total of 3.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 3.21 million shares. There was a decline of -3.75%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 23, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $89 price target.
